← Open Payments lookup

AMY MORIN: Open Payments

NPI 1629617469 · CEDAR RAPIDS, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,809 in 189 payments from 15 companies in 2025. Trend: 2023 $7,809 · 2024 $2,325 · 2025 $3,809

Food & beverage: $2,677Speaker / faculty: $1,125Education: $7
CompanyPaymentsAmount
ABBVIE INC.37$1,596
Otsuka America Pharmaceutical, Inc.21$407
Neurocrine BioSciences, Inc.39$384
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)21$284
Teva Pharmaceuticals USA, Inc.14$202
E.R. Squibb & Sons, L.L.C.13$198
Alkermes, Inc.12$175
Vanda Pharmaceuticals Inc.9$148
Supernus Pharmaceuticals, Inc.9$141
Lundbeck LLC3$77

Products named: VRAYLAR, INGREZZA, REXULTI, CAPLYTA, COBENFY, ARISTADA, AUSTEDO XR, FANAPT.

Industry payments across IA — which companies pay providers there.